PRMT6 and breast cancer: PRMT6 knockdown reduced the number of colonies in U2OS osteosarcoma cells47 as well as in ZR75 and MCF7 breast cancer cells overexpressing proline-, glutamic acid-, and leucine-rich protein 148.